Guerbet S.A.
OTC: GUERF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- David Hale
- Employees
- 2,839
- Headquarters
- Villepinte, France
- IPO year
- 2017
- Market cap
- $281.0M
- Website
- https://www.guerbet.com
Loading GUERF…
Loading profile data…Frequently asked questions about GUERF
What does Guerbet S.A. (GUERF) do?
Guerbet S.A. focuses on pioneering and distributing contrast media, advanced delivery systems, medical devices, and associated technological solutions. Their product lineup features several iodinated contrast agents, including Optiray and Xenetix, which are non-ionic monomeric compounds, alongside Telebrix Gastro, a meglumine ioxitalamate soluti...
Where does GUERF trade?
Guerbet S.A. (GUERF) trades on the Other OTC.
What sector is GUERF in?
Guerbet S.A. (GUERF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Guerbet S.A.?
David Hale is the chief executive officer of Guerbet S.A. (GUERF).
Where is Guerbet S.A. headquartered?
Guerbet S.A. is headquartered in France.
Does GUERF pay a dividend?
Guerbet S.A. (GUERF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GUERF go public?
Guerbet S.A. (GUERF) completed its initial public offering in 2017.